Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2021 Oct 8;429:119925. doi: 10.1016/j.jns.2021.119925

Effect of inactivation mode on second-generation antipsychotic TDM under COVID-19

Yan Zhang 1, Jing Ding 1
PMCID: PMC8498544

Background and aims

To study the effect of heating at 56 °C for 30 min on the monitoring of five second-generation antipsychotics (aripiprazole, quetiapine, risperidone, clozapine and olanzapine).

Methods

After the plasma samples were treated with protein precipitation, the concentrations of aripiprazole, quetiapine, risperidone, clozapine and olanzapine were determined by LC-MS method before and after inactivation of plasma quality control substances and clinical samples. Bland-Ahman method was used to evaluate the difference between the inactivated and non-inactivated determination results, and the correlation between the determination results was analyzed by Passing-Bablok regression and linear regression.

Results

The five second-generation antipsychotics could remain stable after inactivation, and there was no significant difference in matrix effect before and after inactivation of serum quality control substances, and the concentration percentages before and after inactivation were all within the normal range.

Conclusions

The combination of 56 °C for 30 min inactivated protein precipitation treatment method of plasma samples of LC - MS determination o made pp, quetiapine, risperidone, clozapine, olanzapine plasma concentration is affected, the determination results have good consistency and relevance, o can be used to made pp, quetiapine, risperidone, clozapine, olanzapine routine therapeutic drug monitoring.


Articles from Journal of the Neurological Sciences are provided here courtesy of Elsevier

RESOURCES